Pretarget technology: Began Phase I trial

NeoRx Corp. (NERX), Seattle, Wash. Product: Pretarget technology Business: Cancer Therapeutic category: Cytotoxic Target: Tumor cells Description: Separate injections of an antibody fusion protein tum...